Concern and continuity in the care of cancer patients and their carers: development of the intervention
| ISRCTN | ISRCTN43339432 |
|---|---|
| DOI | https://doi.org/10.1186/ISRCTN43339432 |
| Protocol serial number | SDO/13/2001 (e) |
| Sponsor | University College London (UK) |
| Funder | NHS Service and Delivery Organisation (UK) [ref: SDO/13/2001 (e)] |
- Submission date
- 13/09/2005
- Registration date
- 17/10/2005
- Last edited
- 10/05/2012
- Recruitment status
- No longer recruiting
- Overall study status
- Completed
- Condition category
- Cancer
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data
Plain English summary of protocol
Contact information
Prof Michael King
Scientific
Scientific
Dept Mental Health Sciences
Royal Free and University College Medical School
Rowland Hill Street
London
NW3 2PF
United Kingdom
| Phone | +44 (0)20 7794 0500 |
|---|---|
| m.king@medsch.ucl.ac.uk |
Study information
| Primary study design | Interventional |
|---|---|
| Study design | Randomised controlled trial |
| Secondary study design | Randomised controlled trial |
| Study type | Participant information sheet |
| Scientific title | |
| Study objectives | That the development and testing of a complex intervention will lead to improved continuity of care in cancer for patients and those close to them by the delivery of the planned intervention. |
| Ethics approval(s) | Not provided at time of registration |
| Health condition(s) or problem(s) studied | Continuity of care in cancer |
| Intervention | A feasibility (phase II) randomised trial in which we are developing and testing a new intervention - this will be a form of care record for teams in which aspects of continuity of care for each patient will be assessed. ECAP - engagement and continuity action plan: a continuity of care risk assessment completed by secondary care workers at multi-disciplinary meeting. |
| Intervention type | Other |
| Primary outcome measure(s) |
1. Acceptability |
| Key secondary outcome measure(s) |
1. Economic benefits |
| Completion date | 30/09/2007 |
Eligibility
| Participant type(s) | Patient |
|---|---|
| Age group | Adult |
| Lower age limit | 18 Years |
| Sex | All |
| Target sample size at registration | 80 |
| Key inclusion criteria | 1. Aged over 18 years 2. Able to give informed consent 3. Patients diagnosed with breast, lung or colorectal cancer, or their nominated relative or friend |
| Key exclusion criteria | 1. Unable to give informed consent 2. Aged under 18 years |
| Date of first enrolment | 01/04/2006 |
| Date of final enrolment | 30/09/2007 |
Locations
Countries of recruitment
- United Kingdom
- England
Study participating centre
Dept Mental Health Sciences
London
NW3 2PF
United Kingdom
NW3 2PF
United Kingdom
Results and Publications
| Individual participant data (IPD) Intention to share | No |
|---|---|
| IPD sharing plan summary | Not provided at time of registration |
| IPD sharing plan |
Study outputs
| Output type | Details | Date created | Date added | Peer reviewed? | Patient-facing? |
|---|---|---|---|---|---|
| Results article | results | 27/01/2009 | Yes | No | |
| Participant information sheet | Participant information sheet | 11/11/2025 | 11/11/2025 | No | Yes |